Cangene deal

CNJ's partner Organon Teknika N.V. signed a non-exclusive sub-licensing agreement granting Toyobo Co. Ltd. (Osaka) the right to market in Japan CNJ's nucleic acid sequencing-based amplification technology (NASBA) for infectious disease screening and genetic and cancer testing. The NASBA technology allows for the detection of disease at the molecular level. ...